Differences in IP-10, TLR4 and IRF5/3 between SVR and non-SVR HCV-1 patients treated with PEG-IFN and ribavirin
Min Zhang(Central South University), Guozhong Gong(Central South University), Milin Peng(Central South University), Yongfang Jiang(Central South University), Feng Peng(Sichuan University), Xinqiang Xiao(Central South University)
Cited by 4
Related Papers
Psychological impacts and coping strategies of front-line medical staff during COVID-19 outbreak in Hunan, China
|Medical Science Monitor|2020|784
Outcomes of Long-term Treatment of Chronic HBV Infection With Entecavir or Other Agents From a Randomized Trial in 24 Countries
|Clinical Gastroenterology and Hepatology|2019|114
Hyperglycemia is a strong predictor of poor prognosis in COVID-19
|Diabetes Research and Clinical Practice|2020|89
Recent trends of phosphorus-containing flame retardants modified polypropylene composites processing
|Heliyon|2022|78
Induction of apoptosis by norcantharidin in human colorectal carcinoma cell lines: involvement of the CD95 receptor/ligand
|Journal of Cancer Research and Clinical Oncology|2002|77